The cross-regional settlement methods in hospitals and the treatment-seeking behavior of patients with malignant tumors in China: an evolutionary game model

被引:0
作者
Zhao, Xinzhe [1 ]
Li, Linjin [2 ]
Zhang, Dan [2 ]
机构
[1] Genertec Universal Med Grp, Beijing, Peoples R China
[2] Tsinghua Univ, Inst Hosp Management, Tsinghua Shenzhen Int Grad Sch, Shenzhen, Peoples R China
基金
中国国家自然科学基金;
关键词
cross-regional treatment; direct settlement; malignant tumors; treatment-seeking behavior; evolutionary game; HEALTH-CARE ACCESS; CANCER; POPULATION; DISEASE; QUALITY; BURDEN;
D O I
10.3389/fpubh.2024.1427164
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Cross-regional settlement management is a key indicator of national health insurance system maturity. Given the significant demand for cross-regional medical treatment among Chinese patients with malignant tumors and the territorially managed health insurance system, further research is necessary to explore the relationship between hospital settlement methods and treatment-seeking behaviors among these patients. This study introduces and validates an evolutionary game model that provides a theoretical foundation for direct settlement policies in cross-regional treatment.Methods An evolutionary game model was constructed with patients and hospitals serving as strategic players within a dynamic system. This model integrates the patients' treatment utility, medical and nonmedical costs, and hospitals' financial and technological advancement benefits.Results The evolutionary stability analysis revealed seven-game outcomes between hospitals and patients with malignant tumors. The numerical simulations suggest an evolutionary convergence toward strategy (1, 0), indicating a trend where patients with malignant tumors opt for cross-regional treatment, yet hospitals choose not to implement a direct settlement policy. Parameter sensitivity analysis showed that the parameters set in this study affected player behavioral choices and game equilibria.Conclusion A strong demand for cross-regional medical treatment among Chinese patients with malignant tumors, and some hospitals require more incentives to implement cross-regional settlements. The key factors influencing the willingness of some patients with malignant tumors to resettle include the costs of in-area medical care, costs of cross-regional treatment without direct settlement, and the utility of cross-regional treatment. Technological advancement benefits and input costs influence some hospitals' motivation to adopt cross-regional settlements. Policy adjustments that effectively implement direct settlement policies can facilitate equilibrium, enhance the initiatives of some local health insurance management departments, improve the accessibility and efficiency of medical services, and reduce nonmedical expenses for patients.
引用
收藏
页数:17
相关论文
共 79 条
  • [11] The efficacy of telemedicine for pain management in patients with cancer: a systematic review and meta-analysis
    Chen, Wenyu
    Huang, Jie
    Cui, Zhifang
    Wang, Lei
    Dong, Liang
    Ying, Weifeng
    Zhang, Ye
    [J]. THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2023, 14
  • [12] [陈治水 Chen Zhishui], 2020, [中国卫生政策研究, Chinese Journal of Health Policy], V13, P43
  • [13] Epidemiological profile of Brazilian oncological patients seen by a reference oncology center of the public health system and who migrate in search of adequate health care
    Cubero, Daniel I. G.
    de Melo Sette, Claudia Vaz
    Preto Piscopo, Beatriz de Camargo
    de Arruda Monteiro, Camila Ribeiro
    Maselli Schoueri, Jean Henri
    de Andrade Tavares, Heloisa Duarte
    Argani, Igor Luiz
    Garcia, Marilia Arrais
    Passarela, Karoline
    del Giglio, Auro
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2018, 64 (09): : 814 - 818
  • [14] Health Care-Seeking Behaviors, Disease Progression, Medications, Knowledge of, and Attitudes Toward Systemic Lupus Erythematosus in China: Cross-sectional Survey Study
    Dai, Zonglin
    Huang, Xinxiang
    Yuan, Fei
    Li, Tianwang
    Xie, Baozhao
    Lin, He
    Yang, Pingting
    Li, Xueyi
    Xu, Shuiming
    Zhao, Jinjun
    Wang, Yukai
    Peng, Xiang
    Wei, Simin
    Huang, Wei
    Li, Jingyang
    Liang, Jing
    Liu, Xiuhua
    Chu, Yongliang
    Zhang, Zhiming
    Zhang, Renpeng
    Lau, Eric H. Y.
    Lin, Zhiming
    [J]. JMIR PUBLIC HEALTH AND SURVEILLANCE, 2023, 9
  • [15] The role and limits of the European Health Insurance Card: (Too) great expectations?
    De Wispelaere, Frederic
    Berki, Gabriella
    [J]. JOURNAL OF EUROPEAN SOCIAL POLICY, 2021, 31 (04) : 424 - 431
  • [16] Clustering patient mobility patterns to assess effectiveness of health-service delivery
    Delil, Selman
    Celik, Rahmi Nurhan
    San, Sayin
    Dundar, Murat
    [J]. BMC HEALTH SERVICES RESEARCH, 2017, 17
  • [17] Exposing some important barriers to health care access in the rural USA
    Douthit, N.
    Kiv, S.
    Dwolatzky, T.
    Biswas, S.
    [J]. PUBLIC HEALTH, 2015, 129 (06) : 611 - 620
  • [18] Understanding economic and other burdens of terminal illness: The experience of patients and their caregivers
    Emanuel, EJ
    Fairclough, DL
    Slutsman, J
    Emanuel, LL
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) : 451 - +
  • [19] Regional Disparity and Patients Mobility: Benefits and Spillover Effects of the Spatial Network Structure of the Health Services in China
    Fu, Liping
    Xu, Kaibo
    Liu, Feng
    Liang, Lu
    Wang, Zhengmin
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (03) : 1 - 17
  • [20] Regret-sensitive treatment decisions
    Fujii, Yoichiro
    Osaki, Yusuke
    [J]. HEALTH ECONOMICS REVIEW, 2018, 8